Company Analysis

Pulmatrix, Inc. (PULM)

Nasdaq: PULM · Pharmaceutical Preparations · Framingham, MA · filing with the SEC since 2013
Grade6.3
◀ Past 5.8● Present 5.8▶ Future 7.0
3 est.

Filings

379 filings since 2017 beside 88 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company
10-Q Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by Nov 14, 2026
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 44 days after the quarter ended. The proxy statement was last filed Nov 8, 2024.

Filings a yearinsider forms included
7573593827252437
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 4 times in the last 36 months, the newest Nov 13, 2024.SEC letters: 6 in the last 36 months, the newest May 8, 2025.
Insider forms 88

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 9, 2026 425 Merger communication
Oct 30, 2026 425 Merger communication
Oct 27, 2026 8-K item 5.07 Shareholder vote · Current report Oct 26, 2026
Oct 26, 2026 424B3 Shelf offering
Oct 22, 2026 EFFECT Registration effective
Oct 22, 2026 425 Merger communication
Oct 13, 2026 425 Merger communication
Oct 7, 2026 424B3 Shelf offering
Oct 7, 2026 DEFA14A Extra proxy material
Oct 5, 2026 ARS Annual report to shareholders Dec 31, 2025
Oct 5, 2026 S-3/A Shelf registration, amended
Sep 25, 2026 EFFECT Registration effective
Sep 25, 2026 424B3 Shelf offering
Sep 25, 2026 DEFM14A Merger proxy statement
Sep 23, 2026 S-4/A Merger or exchange registration, amended
Sep 22, 2026 425 Merger communication
Sep 17, 2026 S-4/A Merger or exchange registration, amended
Sep 4, 2026 S-4/A Merger or exchange registration, amended
Aug 13, 2026 10-Q Quarterly report Jun 30, 2026
Aug 13, 2026 8-K items 2.02, 9.01 Results released · Current report
Aug 7, 2026 S-3/A Shelf registration, amended
Aug 3, 2026 S-4/A Merger or exchange registration, amended
Jul 9, 2026 S-4 Merger or exchange registration
Jun 16, 2026 10-K/A Annual report, amended Dec 31, 2025
Jun 5, 2026 425 Merger communication
Jun 4, 2026 S-3 Shelf registration
May 15, 2026 10-Q Quarterly report Mar 31, 2026
May 15, 2026 8-K items 2.02, 9.01 Results released · Current report
May 14, 2026 DRS Draft registration, confidential
Apr 22, 2026 SCHEDULE 13D Activist holder notice
Apr 21, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report Apr 16, 2026
Apr 15, 2026 D Private placement notice
Mar 26, 2026 425 Merger communication
Mar 2, 2026 8-K items 1.02, 7.01, 9.01 Major agreement ended; Investor disclosure (Regulation FD) · Current report Feb 28, 2026
Feb 26, 2026 10-K Annual report Dec 31, 2025
Feb 26, 2026 8-K items 2.02, 9.01 Results released · Current report
Dec 18, 2025 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report Dec 17, 2025
Oct 16, 2025 10-Q Quarterly report Sep 30, 2025
Oct 16, 2025 8-K items 2.02, 9.01 Results released · Current report
40 of 379 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton PULM · research, not advice